SARS-CoV-2 specific antibody response after an mRNA vaccine as the third dose: Homologous versus heterologous boost. Lijeskic O, Bauman N, Markovic M, Srbljanovic J, et al. Vaccine 2024 Feb 10:S0264-410X(24)00110-5. doi: 10.1016/j.vaccine.2024.

Read + Share

Amedeo Smart

Independent Medical Education

Lijeskic O, Bauman N, Markovic M, Srbljanovic J, et al. SARS-CoV-2 specific antibody response after an mRNA vaccine as the third dose: Homologous versus heterologous boost. Vaccine 2024 Feb 10:S0264-410X(24)00110-5. doi: 10.1016/j.vaccine.2024.
PMID: 38342717